Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for MDGEF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2019 122.59M
September 30, 2019 127.97M
June 30, 2019 138.48M
March 31, 2019 143.97M
December 31, 2018 142.80M
September 30, 2018 155.63M
June 30, 2018 161.87M
March 31, 2018 132.65M
December 31, 2017 134.41M
September 30, 2017 135.81M
June 30, 2017 136.66M
March 31, 2017 113.20M
December 31, 2016 117.83M
September 30, 2016 129.43M
June 30, 2016 117.32M
March 31, 2016 125.46M
December 31, 2015 123.33M
September 30, 2015 129.18M
June 30, 2015 83.18M
March 31, 2015 74.89M
December 31, 2014 86.26M
September 30, 2014 87.42M
June 30, 2014 78.28M
March 31, 2014 80.97M
December 31, 2013 72.56M
Date Value
September 30, 2013 73.20M
June 30, 2013 74.29M
March 31, 2013 74.82M
December 31, 2012 80.76M
September 30, 2012 80.12M
June 30, 2012 82.02M
March 31, 2012 65.98M
December 31, 2011 69.18M
September 30, 2011 81.03M
June 30, 2011 87.58M
March 31, 2011 94.21M
September 30, 2010 91.33M
June 30, 2010 81.05M
March 31, 2010 85.14M
December 31, 2009 94.30M
September 30, 2009 94.60M
June 30, 2009 99.05M
March 31, 2009 96.67M
December 31, 2008 112.24M
September 30, 2008 125.80M
June 30, 2008 153.97M
March 31, 2008 165.43M
December 31, 2007 168.03M
September 30, 2007 177.06M
June 30, 2007 157.90M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
InflaRx NV 190.83M
BioNTech SE 23.26B
Immatics NV 555.34M
Arrowhead Pharmaceuticals, Inc. 2.112B
Oncolytics Biotech, Inc. 7.671M